Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (rHGH, Insulin, Interferon), Glycosylated (EPO, mAb), Peptides (Calcitonin, Glucagon)), Manufacturing Type (Contract, In-house), Disease (Autoimmune, Oncology) – 2022 to 2027


Category: SKU: GMS815
Clear